Peter Robins

Summary

Affiliation: Thomson Scientific
Country: UK

Publications

  1. ncbi request reprint Japanese Pharmacological Society--77th Annual Meeting. Part I. 8-10 March 2004, Osaka, Japan
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London W1T 4JE, UK
    IDrugs 7:295-7. 2004
  2. ncbi request reprint Japanese Pharmacological Society--77th Annual Meeting. Part II. 8-10 March 2004, Osaka, Japan
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London W1T 4JE, UK
    IDrugs 7:298-300. 2004
  3. ncbi request reprint JPMorgan 25th annual healthcare conference
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:147-8. 2007
  4. ncbi request reprint JPMorgan 25th annual healthcare conference. R&D at Merrimack, Inotek and Gemin X
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:149-51. 2007
  5. ncbi request reprint JPMorgan 25th annual healthcare conference. Pipelines from NovaCardia, Quark Biotech, Raven Biotechnologies and Serenex
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:152-5. 2007
  6. doi request reprint Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
    Catherine Bardelle
    AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    Bioorg Med Chem Lett 18:2776-80. 2008

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Japanese Pharmacological Society--77th Annual Meeting. Part I. 8-10 March 2004, Osaka, Japan
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London W1T 4JE, UK
    IDrugs 7:295-7. 2004
  2. ncbi request reprint Japanese Pharmacological Society--77th Annual Meeting. Part II. 8-10 March 2004, Osaka, Japan
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London W1T 4JE, UK
    IDrugs 7:298-300. 2004
  3. ncbi request reprint JPMorgan 25th annual healthcare conference
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:147-8. 2007
  4. ncbi request reprint JPMorgan 25th annual healthcare conference. R&D at Merrimack, Inotek and Gemin X
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:149-51. 2007
  5. ncbi request reprint JPMorgan 25th annual healthcare conference. Pipelines from NovaCardia, Quark Biotech, Raven Biotechnologies and Serenex
    Peter Robins
    Thomson Scientific, Middlesex House, 34 42 Cleveland Street, London, W1T 4JE, UK
    IDrugs 10:152-5. 2007
  6. doi request reprint Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
    Catherine Bardelle
    AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    Bioorg Med Chem Lett 18:2776-80. 2008
    ..A series of bis-anilinopyrimidines have been identified as potent inhibitors of the tyrosine kinase EphB4. Structural information from two alternative series identified from screening efforts was combined to identify the initial leads...